News Video | Policy | GPs | Hospitals | Medical | Mental Health | Welfare | Search

 

Timing update on Meningococcal Vaccine Strategy


Timing update on Meningococcal Vaccine Strategy

The Ministry of Health today updated progress of the Meningococcal Vaccine Strategy project.

All aspects of the project continue to run smoothly, however the licensure process of the MeNZB? vaccine is taking longer than the current expectations, said Meningococcal Vaccine Strategy Director Dr Jane O?Hallahan. Consequently, this affects the earliest date that the proposed group B meningococcal disease immunisation programme could begin.

The MeNZB? vaccine has been developed to give protection from the specific strain of group B meningococcal disease that has occurred at epidemic levels in New Zealand since 1991.

The Ministry of Health and Counties-Manukau District Health Board had been working closely to plan a launch of the proposed immunisation programme in late May 2004. This timeframe is being reviewed.

?Everything that can be done, is being done,? said Dr O?Hallahan. ?It is disappointing that we cannot proceed further just yet, but the nature and scale of this project means that all timeframes are subject to change. We have always had to plan with flexibility so that we can respond to the unique challenges of developing a vaccine to control an epidemic.

?I am confident that Medsafe is treating the assessment of MeNZB? vaccine as a priority. Until all the necessary evaluation is complete, project teams at the Ministry of Health and Counties-Manukau DHB will continue to work at speed for the earliest possible start of the proposed immunisation programme,? said Dr O?Hallahan.

Dr O?Hallahan also reminded the public to stay vigilant for the signs and symptoms of meningococcal disease. Rates of meningococcal disease continue to be at high levels and the disease?s peak season is approaching.

?Meningococcal B disease continues to strike young New Zealanders seemingly at random. More than 5000 families have now had to cope with the stress and shock of coping with a family member die or be maimed by this horrible disease. Be aware of the warning signs and seek medical attention urgently if someone is sick,? Dr O?Hallahan urged.

Background Q & A

What is the Meningococcal Vaccine Strategy? The MVS project is led by the Ministry of Health and seeks to develop a strain-specific vaccine to control the epidemic of group B meningococcal disease in New Zealand. Pending regulatory approval, a nationwide immunisation programme of MeNZB? would begin. The Meningococcal Vaccine Strategy is one of the country?s largest public health projects.

What does the timing update mean for the public? As the best chance of bringing the meningococcal B epidemic to an end, there is an understandable level of public interest in the progress of the MeNZB?. However, until such time as the vaccine is licensed for use, the timing update is of most interest to the District Health Boards and health professionals involved in planning the first stage of the proposed immunisation programme. The public should continue to be alert for the signs and symptoms of meningococcal disease and seek medical attention if someone is sick. Further information about the proposed immunisation programme will be available as soon as possible.

Does this put the proposed immunisation programme project in doubt? No. Project teams at the Ministry of Health and Counties-Manukau District Health Board will continue to plan for the earliest possible start of the proposed immunisation programme.

When will the Ministry of Health know if the immunisation programme is going ahead or not? The Ministry of Health will make further announcements as soon as possible.

How does this timing update affect planning of the proposed immunisation programme? The first stage of the proposed immunisation programme would begin with a school-based campaign in the Counties Manukau District Health Board area and some suburbs within Auckland District Health Board. Project teams and the Public Health Unit have already begun planning with schools and health professionals, so that the programme could begin as soon as possible. Some aspects of this planning, such as dates booked into school calendars, will be reviewed and rescheduled, as appropriate.

© Scoop Media

 
 
 
Culture Headlines | Health Headlines | Education Headlines

 
Legendary Bassist David Friesen Plays Wellington’s Newest Jazz Venue

Friesen is touring New Zealand to promote his latest album Another Time, Another Place, recorded live at Auckland's Creative Jazz Club in 2015. More>>

Howard Davis Review: The Father - Descending Into The Depths of Dementia

Florian Zeller's dazzling drama The Father explores the effects of a deeply unsettling illness that affects 62,000 Kiwis, a number expected to grow to 102,000 by 2030. More>>


Howard Davis Review: Blade Runner Redivivus

When Ridley Scott's innovative, neo-noir, sci-fi flick Blade Runner was originally released in 1982, at a cost of over $45 million, it was a commercial bomb. More>>

14-21 October: New Zealand Improv Festival In Wellington

Imagined curses, Shibuya’s traffic, the apocalypse, and motherhood have little in common, but all these and more serve as inspiration for the eclectic improvised offerings coming to BATS Theatre this October for the annual New Zealand Improv Festival. More>>

ALSO:

Bird Of The Year Off To A Flying Start

The competition asks New Zealanders to vote for their favourite bird in the hopes of raising awareness of the threats they face. More>>

Scoop Review Of Books:
Jenny Abrahamson's John & Charles Enys: Castle Hill Runholders, 1864-1891

This volume will be of interest to a range of readers interested in the South Island high country, New Zealand’s natural environment, and the history of science. More>>

 
 
 
 
 

LATEST HEADLINES

  • CULTURE
  • HEALTH
  • EDUCATION
 
 
  • Wellington
  • Christchurch
  • Auckland